AI Science Tracker
EN

Department of Orthopedics, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000 China

1 discovery from 2025

Discoveries

Machine learning-enabled identification of nucleus pulposus senescence-associated genes as potential biomarkers for intervertebral disc degeneration

Source check: Source checked. Not independent scientific confirmation.

Finding: Analysis of the GSE70362 gene-expression data identified TAF13 as a candidate nucleus-pulposus senescence-associated marker for intervertebral disc degeneration. Random forest and SVM recursive feature elimination contributed to the selection; qPCR and Western blot in vivo assays, followed by qPCR in human nucleus-pulposus tissue, supported the reported expression pattern. Clinical diagnostic performance or utility was not demonstrated.

Technology: Random forest and SVM recursive feature elimination with co-expression analysis

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Random forest and SVM-RFE prioritized genes associated with disc degeneration; subsequent assays examined the selected TAF13 expression signal.
Test and result
The study analyzed expression profiles and used qPCR and Western blot in vivo, plus qPCR in human nucleus-pulposus samples, to assess TAF13 expression. These assays supported the marker’s expression pattern in the reported material.
Limitation / still unknown
The biomarker claim is not a demonstration of clinical diagnostic performance or utility in an independent prospective patient cohort; expression associations do not establish causality.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12482253/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.